465
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Cell line studies of glioblastoma and malignant glioma using a newly discovered prenylated chalcone

, , , &
Pages 314-318 | Received 18 May 2010, Accepted 11 Aug 2010, Published online: 01 Feb 2011

References

  • Bas D, Boyaci IH. (2007). Modeling and optimization I: Usability of response surface methodology. J Food Eng, 78, 836–845.
  • Cacace JE, Mazza G. (2006). Optimization of extraction of anthocyanins from black currants with aqueous ethanol. J Food Sci, 68, 240–248.
  • Chang YN, Huang JC, Lee CC, Shih IL, Tzeng YM. (2002). Use of response surface methodology to optimize culture medium for production of lovastatin by Monascus rubber. Enzyme Microb Tech, 30, 889–894.
  • Dimmock JR, Elias DW, Beazely MA, Kandepu NM. (1999). Bioactivities of chalcones. Curr Med Chem, 6, 1125–1149.
  • Go ML, Wu X, Liu XL. (2005). Chalcones: An update on cytotoxic and chemoprotective properties. Curr Med Chem, 12, 481–499.
  • Huang WJ, Huang CH, Wu CL, Lin JK, Chen YW, Lin CL, Chuang SE, Huang CY, Chen CN. (2007). Propolin G, a prenylflavanone, isolated from Taiwanese propolis, induces caspase-dependent apoptosis in brain cancer cells. J Agric Food Chem, 55, 7366–7376.
  • Kanadaswami C, Lee LT, Lee PPH, Wang JJH, Ke FC, Huang YT, Lee MT. (2005). The antitumor activities of flavonoids. In Vivo, 19, 895–909.
  • Kondratyuk TP, Pezzuto JM. (2004). Natural product polyphenols of relevance to human health. Pharm Biol, 42, 46–63.
  • Liu HL, Jiang WB, Xie MX. (2010). Flavonoids: Recent advances as anticancer drugs. Recent Pat Anticancer Drug Discov, 5, 152–164.
  • Middleton E. (1996). Biological properties of plant flavonoids: An overview. Pharm Biol, 34, 344–348.
  • Ohgaki H, Kleihues P. (2005). Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol, 64, 479–489.
  • Ren W, Qiao Z, Wang H, Zhu L, Zhang L. (2003). Flavonoids: Promising anticancer agents. Med Res Rev, 23, 519–534.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.